Concerning Pathophysiology and Justifying Clinical Trials

Affiliations

¹ Ottawa Hospital & Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
² Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address: bdewar@ohri.ca.

Comment

Michel Shamy et al. Am J Med. 2021 Jul.

. 2021 Jul;134(7):e439.

doi: 10.1016/j.amjmed.2021.02.022.

¹ Ottawa Hospital & Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
² Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. Electronic address: bdewar@ohri.ca.

No abstract available

Comment in

The Reply.
McCullough PA. McCullough PA. Am J Med. 2021 Jul;134(7):e440-e441. doi: 10.1016/j.amjmed.2021.02.024. Am J Med. 2021. PMID: 34183150 Free PMC article. No abstract available.

Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.
McCullough PA, Kelly RJ, Ruocco G, Lerma E, Tumlin J, Wheelan KR, Katz N, Lepor NE, Vijay K, Carter H, Singh B, McCullough SP, Bhambi BK, Palazzuoli A, De Ferrari GM, Milligan GP, Safder T, Tecson KM, Wang DD, McKinnon JE, O'Neill WW, Zervos M, Risch HA. McCullough PA, et al. Am J Med. 2021 Jan;134(1):16-22. doi: 10.1016/j.amjmed.2020.07.003. Epub 2020 Aug 7. Am J Med. 2021. PMID: 32771461 Free PMC article. Review.

1. McCullough PA, Kelly RJ, Ruocco G, et al. Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. The American Journal of Medicine. 2021;134(1):16–22. doi: 10.1016/j.amjmed.2020.07.003. - DOI - PMC - PubMed
1. Ghazy RM, Almaghraby A, Shaaban R, et al. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment. Scientific Reports. 2020;10(1):22139. doi: 10.1038/s41598-020-77748-x. - DOI - PMC - PubMed
1. Boulware DR, Pullen MF, Bangdiwala AS, et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. New England Journal of Medicine. 2020;383(6):517–525. doi: 10.1056/NEJMoa2016638. - DOI - PMC - PubMed
1. Gandhi RT, Lynch JB, del Rio C. Mild or Moderate Covid-19. New England Journal of Medicine. 2020;383(18):1757–1766. doi: 10.1056/NEJMcp2009249. - DOI - PubMed
1. Group The Recovery Collaborative. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine. 2020;383(21):2030–2040. doi: 10.1056/NEJMoa2022926. - DOI - PMC - PubMed